MoneyWorks4Me

Aurobindo Pharma informs about press release

26 Feb 2026 Evaluate
Aurobindo Pharma has enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Everolimus Tablets, 0.25 mg, 0.5 mg, 0.75 mg and 1 mg.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..